Logen Interactions
There are 299 drugs known to interact with Logen (atropine / diphenoxylate), along with 25 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 7 are major, 274 are moderate, and 18 are minor.
- View all 299 medications that may interact with Logen
- View Logen alcohol/food interactions (2)
- View Logen disease interactions (25)
Most frequently checked interactions
View interaction reports for Logen (atropine / diphenoxylate) and the medicines listed below.
- Anusol (pramoxine/zinc oxide topical)
- aspirin
- cholecalciferol
- Cipro (ciprofloxacin)
- Dulcolax Stool Softener (docusate)
- Effexor (venlafaxine)
- fludrocortisone
- gabapentin
- Generlac (lactulose)
- Implanon (etonogestrel)
- Klonopin (clonazepam)
- Macrobid (nitrofurantoin)
- morphine
- mupirocin topical
- Nitrostat (nitroglycerin)
- Norvasc (amlodipine)
- ondansetron
- oxycodone
- Percocet 5 / 325 (acetaminophen / oxycodone)
- Phenergan (promethazine)
- Plavix (clopidogrel)
- Pletal (cilostazol)
- prednisone
- prochlorperazine
- propoxyphene
- Protonix (pantoprazole)
- Prozac (fluoxetine)
- Ranexa (ranolazine)
- Senokot S (docusate/senna)
- simvastatin
Logen alcohol/food interactions
There are 2 alcohol/food interactions with Logen (atropine / diphenoxylate).
Logen disease interactions
There are 25 disease interactions with Logen (atropine / diphenoxylate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- liver/renal
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- fluid/electrolytes
- hepatic/renal dysfunction
- toxic megacolon
- liver disease
- renal failure
- dehydration
- Down's syndrome
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
QR code containing a link to this page
More about Logen (atropine / diphenoxylate)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
